 0 Table of Contents |
  1 Home |
  2 Business Context |
  3 Capability Statement |
  4 Changelog |
  5 Collect Measurements |
  6 Complete Care Plan |
  7 Consent Based Access Control |
  8 Create Care Plan |
  9 Create Condition |
  10 Create Encounter |
  11 Developer Guide |
  12 Extensions |
  13 Faq |
  14 Health Checks |
  15 History |
  16 In Home Observations |
  17 Initial Assesment |
  18 Rheumatic Fever Data |
  19 Rheumatic Fever Data Models |
  20 Rheumatic Fever Examples Cast |
  21 Roadmap |
  22 Terminology |
  23 Artifacts Summary |
   23.1 Care In The Community ActivityDefinition Apply Operation |
   23.2 Care In The Community PlanDefinition Apply Operation |
   23.3 ManaakiNgaTahiAllergyIntolerance |
   23.4 ManaakiNgaTahiCarePlan |
   23.5 ManaakiNgaTahiCondition |
   23.6 ManaakiNgaTahiDocumentReference |
   23.7 ManaakiNgaTahiEncounter |
   23.8 ManaakiNgaTahiObservation |
   23.9 ManaakiNgaTahiPlanDefinition |
   23.10 ManaakiNgaTahiServiceRequest |
   23.11 ServiceRequestActivityDefinition |
   23.12 Template for COVID-19 Care in the Community CCCM MVP Careplans |
   23.13 Vital Signs Observation Service Request |
   23.14 AIR - Overseas, Historic, Not Done |
   23.15 Antiviral medication eligibility questionnaire |
   23.16 COVID-19 RAT Result Questionnaire |
   23.17 COVID19 Initial Health Assessment Questionnaire |
   23.18 COVID19 Public Health History Questionnaire |
   23.19 COVID19 Vaccination Side Effects Questionnaire |
   23.20 Measles Daily Health Check |
   23.21 Mental Health Assessment Survey |
   23.22 Post Vaccine Symptom Check day 3 survey |
   23.23 Post Vaccine Symptom Check day 42 survey |
   23.24 Pregnancy Assessment Survey |
   23.25 Question Template for COVID-19 Regular Health Check |
   23.26 Report a Rapid Antigen Test (RAT) result |
   23.27 ActiveMonitoringDay3SurveyQuestionnaireResponse |
   23.28 ActiveMonitoringDay42SurveyQuestionnaireResponse |
   23.29 AntiviralEligibilityNoQuestionnaireResponse |
   23.30 AntiviralEligibilityYesQuestionnaireResponse |
   23.31 ConsumerCOVIDRATResultQuestionnaireResponse |
   23.32 COVIDInitialHealthAssessmentQuestionnaireResponse |
   23.33 COVIDPublicHealthHistoryQuestionnaireResponseSherrylCarrion |
   23.34 COVIDRATResultQuestionnaireResponse |
   23.35 COVIDRegularHealthCheckQuestionnaireResponse |
   23.36 COVIDVaccinationSurveyQuestionnaireResponse |
   23.37 ImmsotVaccinationDataEntryQuestionnaireResponse |
   23.38 MeaslesHealthCheckQuestionnaireResponse |
   23.39 MentalHealthAssessmentSurveyQuestionnaireResponse |
   23.40 PregnancyAssessmentSurveyQuestionnaireResponse |
   23.41 CareyCarrington |
   23.42 ConditionExample |
   23.43 COVID-19 Omicron Response - Carey Carrington |
   23.44 DocumentReferenceExample |
   23.45 DrDottyMcStuffins |
   23.46 EncounterExample |
   23.47 ObservationExample |
   23.48 ObservationsServiceRequestExample |
   23.49 Certainty of rheumatic fever diagnosis |
   23.50 Codifies role taken by a whanau member of patient's care team |
   23.51 Date of assessment of rheumatic heart disease severity |
   23.52 Denotes if the member is to be used a primary contact |
   23.53 Frequency of rheumatic fever medication |
   23.54 Medications and Follow-up Guidance Questionnaire |
   23.55 Patient & whanau goals and preferences questionnaire |
   23.56 Reason a rheumatic fever care plan was closed (#revoked status) |
   23.57 Reason rheumatic fever care plan changed to on-hold status |
   23.58 Relationship of whanau member to patient in care team |
   23.59 Rheumatic Fever Care Team |
   23.60 Rheumatic Fever CarePlan |
   23.61 Rheumatic Fever Condition |
   23.62 Rheumatic Fever Medication Request |
   23.63 Rheumatic Fever Patient |
   23.64 Secondary Prophylaxis Health Assessment Questionnaire |
   23.65 Secondary prophylaxis medication allergy questionnaire |
   23.66 Severity of rheumatic heart disease |
   23.67 Active care plan with medication planned and appointments booked for Madeleine Meringue |
   23.68 Basic care plan representing only the registration of Madeleine Meringue |
   23.69 Care plan closed with only one appointment completed |
   23.70 Care plan underway for Madeleine Meringue with one appointment completed |
   23.71 Care plan went on hold after first appointment completed |
   23.72 Draft care plan for Madeleine Meringue (no secondary prevention planned) |
   23.73 Encounter-SecondaryProphylaxisAppointment |
   23.74 LeadProvidersGroup |
   23.75 MadeleineMeringue |
   23.76 MadeleineMeringueAndWhanau |
   23.77 MedicationsAndFollowUpGuidanceQuestionnaireResponse |
   23.78 MedicationStatement-August |
   23.79 PaniaPunga |
   23.80 PatientMedicationAllergyQuestionnaireResponse |
   23.81 PatientWhanauGoalsPreferencesQuestionnaireResponse |
   23.82 PlannedMedicationRequestExample |
   23.83 RFPatientHealthAssessmentQuestionnaireResponse |
   23.84 SecondaryProphylaxisAppointment-August-Booked |
   23.85 SecondaryProphylaxisAppointment-August-Fulfilled |
   23.86 SecondaryProphylaxisAppointment-September-Booked |
   23.87 SecondaryProphylaxisAugustEncounterBundle |
   23.88 SecondaryProphylaxisCareTeam |
   23.89 SecondaryProphylaxisMedicationExample |
   23.90 SevereRfConditionExample |
   23.91 TeTaiTokerauRFSecondaryPreventionService |
   23.92 WaikatoRFSecondaryPreventionService |
   23.93 Codes for certainty of diagnosis of rheumatic fever condition |
   23.94 Codes for certainty of rheumatic fever diagnosis |
   23.95 Codes for differentiating types of external identifiers held in FHIR resource Identifiers |
   23.96 Codes for rheumatic fever condition as diagnosed at patient registration |
   23.97 External identifier type codes |
   23.98 Generic QuestionnaireResponse yes/no question answer codes |
   23.99 Rheumatic fever care plan category codes |
   23.100 Rheumatic fever care team category codes |
   23.101 Rheumatic fever medication allergy codes |
   23.102 Rheumatic fever patient care team participant role codes |
   23.103 Rheumatic fever planned medication frequency codes |
   23.104 Rheumatic heart disease severity codes |
   23.105 ManaakiNgaTahiConsent |
   23.106 Question Template for COVID-19 Privacy Statement Question |
   23.107 ConsentByQuestionnaireExample |
   23.108 ConsentByRelatedPersonExample |
   23.109 ConsentExample |
   23.110 ConsentQuestionnaireResponseExample |
   23.111 ProposedConsentBaseExample |
   23.112 ProposedConsentCoverageExample |
   23.113 RheumaticFeverActiveConsentExample |
   23.114 Care In The Community FHIR Server Capability Statement |
   23.115 COVID19 vaccines recognised by NZ public health |
   23.116 Codings for COVID-19 vaccination brands recognised in New Zealand public health |
   23.117 AllergyIntoleranceExample |
   23.118 Template for COVID-19 Care in the Community CCCM MVP Careplans |